| patient age/yearsmedian (range) | 72 (59-83) | 71 (61-81) |
| PTVprostate /ccmedian (range) | 142 (35-310) | 163 (70-537) |
| PTVboost /ccmedian (range) | 17 (4-46) | - |
| % PSA ≤10 ng/mL | 74% | 76% |
| % Gleason score ≤6 | 65% | 71% |
| % T-stage ≤2a | 78% | 86% |
| % NHT | 17% | 19% |
| bladder volume/ccmedian (range) | 237 (69-645) | 225 (98-493) |
| rectum volume/ccmedian (range) | 88 (36-235) | 81 (48-252) |
| EUD PTVprostate*/Gymedian (range) | 76.7 (73.8-78.3) | 76.0 (74.3-77.1) |
| EUD PTVboost /Gymedian (range) | 79.5 (76.6-80.5) | - |
| EUD bladder/Gymedian (range) | 55.6 (41.7-63.2) | 54.6 (45.0-62.3) |
| EUD rectum/Gymedian (range) | 55.9 (47.1-62.4) | 54.6 (40.1-60.6) |
| NTCP bladder/%median (range) | 0 (0-0.6) | 0 (0-0.4) |
| NTCP rectum/%median (range) | 6.9 (2.2-14.7) | 5.5 (1.5-11.2) |